OBJECTIVES: To assess outcomes of prenatally diagnosed tetralogy of Fallot and determine factors associated with the choice to undergo a valvesparing repair versus transannular patch, and the use of prostaglandins at birth. METHODS: All cases at The Hospital for Sick Children (Toronto, Ontario) with a fetal diagnosis of tetralogy of Fallot from 1998 to 2006, were reviewed for demographic and fetal echocardiographic data to determine factors associated with the valve-sparing repair and need for perinatal support. RESULTS: Sixty-four fetuses met inclusion criteria (median gestational age 22 weeks) with 47 live births. Twenty-six underwent valve-sparing repair (median age 5.7 months) and 14 underwent transannular patch repair (median age 4.5 months). There were seven deaths before surgery and one post-transannular patch repair. One patient required a transannular patch repair after the initial valve-sparing repair. Twelve of 29 (41%) patients received prostaglandins at birth. Type of surgical repair, use of prostaglandins and postnatal death were among the outcomes investigated. The mean pulmonary valve (PV) z-score was -3.0+/-2.0 and the mean PV/aortic valve (AoV) ratio was 0.65+/-0.10. Lower PV z-score (P=0.04), smaller PV/AoV ratio (P=0.04) and the presence of nonantegrade arterial duct flow (P=0.02) were associated with prostaglandin use. A higher PV/AoV ratio was associated with valvesparing repair (P=0.04). Fetal z-scores of the PV, AoV and right pulmonary artery at 29 to 32 weeks gestational age correlated with respective postnatal z-scores (P=0.01). CONCLUSION: Fetal echocardiographic variables were associated with the use of prostaglandins and valve-sparing repair in fetuses with tetralogy of Fallot, and at 29 weeks, correlated with postnatal valve diameters.
OBJECTIVES: To assess outcomes of prenatally diagnosed tetralogy of Fallot and determine factors associated with the choice to undergo a valvesparing repair versus transannular patch, and the use of prostaglandins at birth. METHODS: All cases at The Hospital for Sick Children (Toronto, Ontario) with a fetal diagnosis of tetralogy of Fallot from 1998 to 2006, were reviewed for demographic and fetal echocardiographic data to determine factors associated with the valve-sparing repair and need for perinatal support. RESULTS: Sixty-four fetuses met inclusion criteria (median gestational age 22 weeks) with 47 live births. Twenty-six underwent valve-sparing repair (median age 5.7 months) and 14 underwent transannular patch repair (median age 4.5 months). There were seven deaths before surgery and one post-transannular patch repair. One patient required a transannular patch repair after the initial valve-sparing repair. Twelve of 29 (41%) patients received prostaglandins at birth. Type of surgical repair, use of prostaglandins and postnatal death were among the outcomes investigated. The mean pulmonary valve (PV) z-score was -3.0+/-2.0 and the mean PV/aortic valve (AoV) ratio was 0.65+/-0.10. Lower PV z-score (P=0.04), smaller PV/AoV ratio (P=0.04) and the presence of nonantegrade arterial duct flow (P=0.02) were associated with prostaglandin use. A higher PV/AoV ratio was associated with valvesparing repair (P=0.04). Fetal z-scores of the PV, AoV and right pulmonary artery at 29 to 32 weeks gestational age correlated with respective postnatal z-scores (P=0.01). CONCLUSION: Fetal echocardiographic variables were associated with the use of prostaglandins and valve-sparing repair in fetuses with tetralogy of Fallot, and at 29 weeks, correlated with postnatal valve diameters.
Authors: G Norgård; M A Gatzoulis; F Moraes; C Lincoln; D F Shore; E A Shinebourne; A N Redington Journal: Circulation Date: 1996-12-15 Impact factor: 29.690
Authors: G S Van Arsdell; G S Maharaj; J Tom; V K Rao; J G Coles; R M Freedom; W G Williams; B W McCrindle Journal: Circulation Date: 2000-11-07 Impact factor: 29.690
Authors: J G Murphy; B J Gersh; D D Mair; V Fuster; M D McGoon; D M Ilstrup; D C McGoon; J W Kirklin; G K Danielson Journal: N Engl J Med Date: 1993-08-26 Impact factor: 91.245
Authors: Fernando A Atik; Edmar Atik; Claudio R da Cunha; Luiz Fernando Caneo; Renato S Assad; Marcelo B Jatene; Arlindo Riso; Miguel Barbero-Marcial Journal: Eur J Cardiothorac Surg Date: 2004-02 Impact factor: 4.191
Authors: Aungkana Gengsakul; Louise Harris; Timothy J Bradley; Gary D Webb; William G Williams; Samuel C Siu; Naeem Merchant; Brian W McCrindle Journal: Eur J Cardiothorac Surg Date: 2007-07-12 Impact factor: 4.191
Authors: L K Hornberger; S P Sanders; D J Sahn; M J Rice; P J Spevak; B R Benacerraf; R W McDonald; S D Colan Journal: J Am Coll Cardiol Date: 1995-03-01 Impact factor: 24.094
Authors: Christine E MacColl; Cedric Manlhiot; Christiana Page; Brian W McCrindle; Steven E S Miner; Edgar T Jaeggi; Lynne E Nield Journal: Pediatr Cardiol Date: 2014-06-14 Impact factor: 1.655
Authors: Bhawna Arya; Stéphanie M Levasseur; Kristal Woldu; Julie S Glickstein; Howard F Andrews; Ismée A Williams Journal: Pediatr Cardiol Date: 2013-12-19 Impact factor: 1.655